Unusual paraseptal emphysema as the primary changes in computerized tomography scan of a COVID-19 patient. Case report

Dan Bendtsen, Takkin Lo

Abstract

Covid-19 pandemic has infected more than 20 million people worldwide and claimed more than 750,000 lives so far. Given that this disease is new, the long-term lung effects for survivors especially of severe cases are unknown.

Most radiographic changes compared to those commonly seen in Acute Respiratory Distress Syndrome (ARDS), manifested as groundglass opacities or diffuse interstitial/alveolar changes.

We present a case of severe acute respiratory failure secondary to COVID-19 requiring prolonged mechanical ventilation and hospitalization with subsequent lung damage and unusual formation of extensive paraseptal emphysematous changes which predominantly affect the lungs apices with subsequent spontaneous pneumothorax.

Currently, the long-term impacts on survivors of severe COVID-19 infections are unknown.  Future long-term follow-up studies will likely confirm a significant burden and many long-lasting disabilities to the society.

Keywords

COVID-19, VILI, Paraseptal Emphysema, Pulmonary fibrosis, Pneumothorax

References

1. Komorowski M, Aberegg SK. Using applied lung physiology to understand COVID-19 patterns. Br J Anaesth 2020 [published online ahead of print, 2020 May 26]. https://doi.org/10.1016/j.bja.2020.05.019 PMid:32536444 PMCid:PMC7250770

2. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/. Accessed 2020 Aug 13.

3. Jun Zheng. SARS-CoV-2: an Emerging Coronavirus that causes a Global Threat. Int J Biol Sci 2020; 16(10):1678-1685. https://doi.org/10.7150/ijbs.45053 PMid:32226285 PMCid:PMC7098030

4. Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 2020; 581:221-224. https://doi.org/10.1038/s41586-020-2179-y PMid:32225175 PMCid:PMC7328981

5. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8:420-422. https://doi.org/10.1016/S2213-2600(20)30076-X

6. Ackermann M, Verleden SE, Kuehnel M, et al.Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383:120-128. https://doi.org/10.1056/NEJMoa2015432 PMid:32437596 PMCid:PMC7412750

7. Adams HJA, Kwee TC, Yakar D, et al. Chest CT Imaging Signature of COVID-19 Infection. In Pursuit of the Scientific Evidence. Chest 2020; 158(5):1885-1895.  https://doi.org/10.1016/j.chest.2020.06.025 PMID: 32592709  PMCID: PMC7314684

8. Adams HJA, Kwee TC, Yakar D, et al. Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19). Am J Roentgenol. 2020;1-9.[published online ahead of print, 2020 Jun 1] https://doi.org/10.2214/AJR.20.23391 PMid:32478562

9. Burnham EL, Janssen WJ, Riches DW, et al. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J 2014; 43(1):276-285. https://doi.org/10.1183/09031936.00196412 PMid:23520315 PMCid:PMC4015132

10. Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Research 2020; 8:8. https://doi.org/10.1038/s41413-020-0084-5 PMid:32128276 PMCid:PMC7018717

11. Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 2017; 27: 342-349. https://doi.org/10.4103/ijri.IJRI_469_16 PMid:29089687 PMCid:PMC5644332

12. Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med 2020; 8(8):750-752. https://doi.org/10.1016/S2213-2600(20)30222-8

13. Delpino MV, Quarleri J. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis Front Cell Infect Microbiol 2020; 10:340-344. https://doi.org/10.3389/fcimb.2020.00340 PMid:32596170 PMCid:PMC7303284

14. Hu HH, Chen DQ, Want YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact 2018; 292(8):76-83. https://doi.org/10.1016/j.cbi.2018.07.008 PMid:30017632

15. Cabrera-Benitez NE, Laffey JG, Parotto M, et al. Mechanical Ventilation-associated Lung Fibrosis in Acute Respiratory Distress Syndrome A Significant Contributor to Poor Outcome. Anesthesiology 2014; 121(1):189-198. https://doi.org/10.1097/ALN.0000000000000264 PMid:24732023 PMCid:PMC4991945

16. Slutsky AS, Ranieri VM.Ventilator-induced lung injury. N Engl J Med 2013; 369(22):2126-2136. https://doi.org/10.1056/NEJMra1208707 PMid:24283226

17. Determann RM , Millo JL, Gibot S, et al Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005; 31(11):1495-1500. https://doi.org/10.1007/s00134-005-2818-7 PMid:16195904

18. Ucpinar BA, Sahin C, Yanc U. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case Report. J Infect Public Health 2020; 13(6):887-889. https://doi.org/10.1016/j.jiph.2020.05.012 PMid:32475804 PMCid:PMC7247978

19. Poggiali E, Vercelli A, Iannicelli T, et al. COVID-19, Chronic Obstructive Pulmonary Disease and Pneumomothorax: A frightening Triad. Eur J Case Rep Intern Med 2020; 7(7):001742.

20. Chiumello D, Coppola S, Froio S, et al. What’s Next After ARDS: Long-Term Outcomes. Respir Care 2016; 61(5):689-699. https://doi.org/10.4187/respcare.04644 PMid:27121623

21. Sasidhar M, Chatburn RL. Tidal Volume Variability During Airway Pressure Release Ventilation: Case Summary and Theoretical Analysis. Respir Care 2012; 57(8):1325-1333. https://doi.org/10.4187/respcare.01394 PMid:22348242